BLU-5937
Phase 2- Indications
- Refractory chronic cough, Chronic pruritus associated with atopic dermatitis
Company intelligence / Profile preview
No clinical results or pipeline information publicly disclosed; appears to be a service provider rather than a therapeutics developer[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Picchio International Inc..